Arimoclomol

An investigational drug for neurodegenerative diseases

Arimoclomol
INN
Drug class
Routes of administration
Pregnancy category
Bioavailability
Metabolism
Elimination half-life
Excretion
Legal status
CAS Number
PubChem
DrugBank
ChemSpider
KEGG

Arimoclomol is a pharmacological agent that has been investigated for its potential therapeutic effects in various neurodegenerative diseases. It is known for its ability to modulate the heat shock response, a cellular defense mechanism against stress.

Mechanism of Action

Arimoclomol functions by amplifying the production of heat shock proteins (HSPs), which are crucial in maintaining cellular protein homeostasis. These proteins assist in the proper folding of nascent proteins and the refolding or degradation of misfolded proteins, thus protecting cells from stress-induced damage. By enhancing the heat shock response, arimoclomol aims to mitigate the pathological processes associated with neurodegenerative conditions.

Therapeutic Applications

Arimoclomol has been studied in the context of several neurodegenerative disorders, including:

• Amyotrophic lateral sclerosis (ALS)
• Niemann-Pick disease type C
• Inclusion body myositis

In these conditions, the accumulation of misfolded proteins and cellular stress are key pathological features. Arimoclomol's ability to boost the heat shock response offers a potential therapeutic strategy to alleviate these issues.

Clinical Trials

Clinical trials have been conducted to evaluate the efficacy and safety of arimoclomol in patients with neurodegenerative diseases. These trials aim to determine the drug's impact on disease progression, symptom management, and overall quality of life for patients.

Safety and Side Effects

The safety profile of arimoclomol has been assessed in various clinical studies. Common side effects reported include mild gastrointestinal disturbances and headache. The drug is generally well-tolerated, but ongoing studies continue to monitor its long-term safety.

Future Directions

Research into arimoclomol is ongoing, with scientists exploring its potential applications in other diseases characterized by protein misfolding and cellular stress. The drug's ability to modulate the heat shock response makes it a promising candidate for further investigation in the field of neurodegeneration.

Related Pages

• Heat shock protein
• Neurodegenerative disease
• Protein folding

• Arimoclomol
• 

  Arimoclomol

• Arimoclomol
• 

  Arimoclomol